Park Ha Biological Technology Co., Ltd. Announces Membership Application to Personal Care Products Council (PCPC), Aligning the Brand with International Standards and Marking a Strategic Milestone in its Expansion into Amazon North America

Rhea-AI Summary

Park Ha Biological (NASDAQ: PHH) has filed a complete membership application to the Personal Care Products Council (PCPC). The application includes corporate qualifications, raw material compliance, and product safety data under review, supporting its planned expansion into Amazon North America and broader U.S. personal care markets.

AI-generated analysis. How Rhea-AI works. Not financial advice.

What This Means

This announcement underscores BYAH’s effort to meet PCPC and U.S. regulatory expectations as it targ...

Analysis

This announcement underscores BYAH’s effort to meet PCPC and U.S. regulatory expectations as it targets Amazon North America. Existing Nasdaq bid-price and $35 million MVLS deficiencies, alongside 15,000,000,000 authorized shares, remain key overhangs to monitor against execution on this expansion plan.

Key Figures

Minimum bid price: $1 per share MVLS requirement: $35 million Compliance deadline: March 2, 2026 +5 more

8 metrics

Minimum bid price $1 per share Nasdaq Listing Rule 5550(a)(2) deficiency notice

MVLS requirement $35 million Nasdaq Listing Rule 5550(b)(2) deficiency notice

Compliance deadline March 2, 2026 Deadline to regain Nasdaq listing compliance

Authorized ordinary shares 15,000,000,000 shares Post-AGM capital redesignation authorization

Class A shares authorized 12,000,000,000 shares Authorized with 1 vote per share

Class B shares authorized 3,000,000,000 shares Authorized with 20 votes per share

Share incentive increase 4,500,000 shares Additional S-8 registration for 2025 Share Incentive Plan

PCPC representation over 90% of major U.S. cosmetics and skincare companies PCPC member coverage in North American personal care industry

Regulatory & Risk Context

Short Interest: 0.6%

Short Interest

0.6% of shares outstanding

as of 2025-10-15 Days to cover: 1

Reported short interest appears relatively low, implying limited squeeze dynamics and suggesting that day-to-day price swings are more likely to be driven by news flow, liquidity, and listing-compliance developments than by forced short covering.

Key Terms

modernization of cosmetics regulation act of 2022, food and drug administration (fda), international nomenclature of cosmetic ingredients (inci), market value of listed securities

4 terms

modernization of cosmetics regulation act of 2022 regulatory

"including the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), Food and Drug"

A federal law that modernizes how cosmetic products are overseen by giving regulators clearer authority to require safety records, product listings, adverse-event reporting, and facility inspections. For investors it matters because the rulebook can raise compliance costs, change which products can be sold, and shift legal and supply-chain risks for manufacturers—think of it like new building codes that affect construction costs and market access.

food and drug administration (fda) regulatory

"of 2022 (MoCRA), Food and Drug Administration (FDA) cosmetic standards, and the"

A U.S. government agency that reviews and approves drugs, medical devices, vaccines, food safety measures and related products before they reach the market. Think of it as a gatekeeper whose decisions, inspections and safety warnings can make or break a product’s ability to sell; investors watch FDA actions closely because approvals speed revenue and failed reviews, delays or recalls can sharply change a company’s value.

international nomenclature of cosmetic ingredients (inci) regulatory

"Administration (FDA) cosmetic standards, and the International Nomenclature of Cosmetic Ingredients (INCI)"

A standardized system of names used on cosmetic and personal-care product ingredient lists so the same substance is identified the same way across countries and languages. Think of it as a common recipe language that helps regulators, retailers and consumers check what is in a product; for investors, INCI names affect regulatory approval, labeling costs, market access and consumer trust, all of which can influence sales and legal risk.

market value of listed securities regulatory

"its Market Value of Listed Securities had remained below the required $35 million for 30 consecutive"

The market value of listed securities is the total worth of stocks, bonds and other tradable instruments quoted on an exchange, measured using the prices investors are willing to pay right now. It’s calculated by multiplying each security’s current market price by the number of units outstanding and adding those amounts together, like totaling the value of every item in a store at today’s prices. Investors watch this because it shows the size, liquidity and overall health of the market or a company’s publicly traded portion, and it influences index weights, fund allocations and perceived risk.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Wuxi, China, July 01, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that it has formally filed a complete membership application with the Personal Care Products Council (PCPC). The submission encompasses all requisite corporate qualifications, raw material compliance documentation, and product safety materials, all of which are currently under review. This application marks a pivotal step in establishing the Company’s comprehensive compliance framework for the North American market, facilitating its planned entry into Amazon’s North America marketplace, and securing access to the technical, regulatory, and industry resources essential for success in the U.S. personal care sector.

Founded in 1894, PCPC is the preeminent trade association for the personal care industry in North America, serving as the primary architect and authoritative interpreter of key regulatory frameworks, including the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), Food and Drug Administration (FDA) cosmetic standards, and the International Nomenclature of Cosmetic Ingredients (INCI) ingredient naming system. PCPC represents over 90% of major U.S. cosmetics and skincare companies, with global industry leaders such as Estée Lauder, L’Oréal, Procter & Gamble, Unilever, Beiersdorf, and Kiehl’s among its long-standing members. PCPC’s industry recognition and compliance endorsement carry substantial weight, with membership status widely regarded as a definitive benchmark for brands seeking compliant access to North American e-commerce and retail channels.

As a technology-driven skincare brand committed to comprehensive expansion in the North American market, Park Ha Biological has proactively secured industry access qualifications, meticulously compiled required application materials, and systematically advanced the membership verification process.

The head of the Brand Overseas Division of the Company emphasized that North America’s stringent regulatory landscape demands proactive engagement, and joining PCPC is a cornerstone of the Company’s long-term globalization strategy. Through PCPC’s extensive global membership network, Park Ha Biological aims to forge connections with established North American brands, leading contract manufacturers, raw material suppliers, and testing laboratories, thereby building a resilient overseas supply chain to support both its upcoming Amazon online operations and future offline retail expansion.

The PCPC membership application has been advanced in parallel with the Company’s cooperation with Amazon North America, supporting the establishment of a comprehensive and robust compliance framework for its international expansion.

About Park Ha Biological Technology Co., Ltd.

Established in 2016, Park Ha Biological Technology Co., Ltd. is primarily engaged in developing its private skincare label, direct skincare product sales and franchise promotion under the proprietary brand “Park Ha”, with a commitment to providing cost-effective solutions to skin problems and improving the confidence of women in need of skin treatment. As of October 31, 2025, the Company has five directly operated stores and 22 franchisees in China. As part of its value-added service for the products, the Company offers “light beauty experience”, a quick complimentary after-sales beauty service performed in the directly operated stores and franchise stores. For more information, please visit the Company’s website: http://ir.parkha.cn/.   

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects, “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions in this announcement. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.

For more information, please contact:

Park Ha Biological Technology Co., Ltd.
901 & 901-2, Building C
Phase 2, Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000
ir_parkha@163.com

FAQ

What did Park Ha Biological (NASDAQ: PHH) announce about its PCPC membership application on July 1, 2026?

Park Ha Biological announced it has submitted a complete membership application to the Personal Care Products Council. According to Park Ha Biological, the file includes corporate qualifications, raw material compliance documentation, and product safety materials that are now under review by the trade association.

How does Park Ha Biological’s PCPC membership application support its Amazon North America expansion (PHH)?

The PCPC application is intended to strengthen Park Ha Biological’s compliance framework for entering Amazon North America. According to Park Ha Biological, it should help secure regulatory, technical, and industry resources needed for successful participation in U.S. online personal care channels.

Why is joining the Personal Care Products Council important for Park Ha Biological (PHH)?

Joining PCPC is described as a cornerstone of Park Ha Biological’s long-term globalization strategy. According to Park Ha Biological, PCPC membership is widely viewed as a benchmark for compliant access to North American e-commerce and retail personal care markets.

What benefits does Park Ha Biological expect from PCPC’s global network for its PHH skincare brand?

Park Ha Biological expects PCPC’s network to enable connections with North American brands, contract manufacturers, suppliers, and testing labs. According to Park Ha Biological, these relationships may help build a resilient overseas supply chain for Amazon operations and future offline retail expansion.

How is Park Ha Biological addressing North American regulatory requirements for its PHH products?

Park Ha Biological is pursuing PCPC membership to align with frameworks like MoCRA, FDA cosmetic standards, and INCI. According to Park Ha Biological, this supports a comprehensive, robust compliance framework for its international expansion, including Amazon North America and potential offline retail channels.